Krystal Biotech Inc

KRYSNASDAQ · USD
350.88USD0.00 (+5.11%)
5210

Krystal Biotech Inc (KRYS) Straddle

KRYS straddle scan found 173 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 50.2%.

Read more

Trading a KRYS straddle lets you take a pure volatility position on Krystal Biotech Inc without committing to a direction. Krystal Biotech Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate KRYS straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on KRYS profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Krystal Biotech Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the KRYS straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome.

Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the KRYS straddle is the cleanest expression of that view. Our scanner prices every KRYS straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a KRYS straddle into a catalyst or short a KRYS straddle to harvest decay, the options straddle setups that matter are all in one place.

Feb 19, 2027560.00$224.601551%50.2%$784.60$335.400
Feb 19, 2027540.00$205.701551%49.6%$745.70$334.300
Mar 19, 2027560.00$227.151831%49.3%$787.15$332.850
Sep 18, 2026400.00$61.4011%49.2%$461.40$338.600
Nov 20, 2026440.00$104.13641%49.0%$544.13$335.882
Feb 19, 2027520.00$187.601551%48.7%$707.60$332.400
Mar 19, 2027540.00$208.901831%48.5%$748.90$331.100
Oct 16, 2026380.00$44.58291%48.2%$424.58$335.430
Jun 17, 2027560.00$233.202731%48.1%$793.20$326.800
Nov 20, 2026430.00$96.10641%47.6%$526.10$333.9010

As of September 22, 2026

Find the right straddle before volatility moves

Track KRYS straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial